One mechanism by which HER2 restricts Notch signaling was identified by Ju et al. These investigators showed that HER2 overexpressing breast cancer cells activate the ERK pathway to block the activity of the γ-secretase complex thus resulting in reduced levels of NICD1. This evidence concerns the gene ERBB2 and breast carcinoma.